ATG5 involved in autophagic vesicle formation. Conjugation with ATG12, through a ubiquitin-like conjugating
system involving ATG7 as an E1-like activating enzyme and ATG10 as an E2-like conjugating enzyme, is essential
for its function. The ATG12-ATG5 conjugate acts as an E3-like enzyme which is required for lipidation of ATG8
family proteins and their association to the vesicle membranes. Involved in mitochondrial quality control after
oxidative damage, and in subsequent cellular longevity. The ATG12-ATG5 conjugate also negatively regulates the
innate antiviral immune response by blocking the type I IFN production pathway through direct association with
RARRES3 and MAVS. Also plays a role in translation or delivery of incoming viral RNA to the translation
apparatus. Plays a critical role in multiple aspects of lymphocyte development and is essential for both B and T
lymphocyte survival and proliferation. Required for optimal processing and presentation of antigens for MHC II.
Involved in the maintenance of axon morphology and membrane structures, as well as in normal adipocyte
differentiation. Promotes primary ciliogenesis through removal of OFD1 from centriolar satellites and degradation
of IFT20 via the autophagic pathway
Aliases : ASP; APG5; APG5L; hAPG5; APG5-LIKE
Entrez GeneID : 9474
Swissprot : Q9H1Y0
WB Predicted band size : 32.4kDa
Host/Isotype : Mouse IgG2a
Species Reactivity : Human
Immunogen : Synthesized peptide of human ATG5 (AA: MTDDKDVLRDVWFGRIc).
